newsfilter
← Latest News
ClinicalTrials.gov·

C-CAR066 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL) - NCT05784441

Calculate the incidence of adverse events, Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 dose (RP2D), Determine the overall response rate (ORR), (and 3 more...)